Fernando Alberto Goldbaum Selected Research

Riboflavin Synthase

1/2019

A high-throughput screening for inhibitors of riboflavin synthase identifies novel antimicrobial compounds to treat brucellosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fernando Alberto Goldbaum Research Topics

Disease

5	Brucellosis (Malta Fever) 01/2019 - 02/2010
3	Infections 03/2019 - 07/2012
1	Neoplasms (Cancer) 01/2020
1	Epididymitis 03/2019
1	Zoonoses 01/2019
1	Communicable Diseases (Infectious Diseases) 12/2015

Drug/Important Bio-Agent (IBA)

6	VaccinesIBA 01/2020 - 07/2012
3	AntigensIBA 03/2019 - 05/2016
1	micaIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	6,7-dimethyl-8-ribityllumazine synthase (lumazine synthase)IBA 01/2020
1	Riboflavin SynthaseIBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	ChitosanIBA 05/2016
1	Protease Inhibitors (Protease Inhibitor)IBA 12/2015
1	Brucella unlipidated outer membrane protein 19IBA 12/2015
1	Oxygen (Dioxygen)IBA 07/2012
1	EnzymesIBA 02/2010
1	4,6-dinitro-o-cresol (DNOC)IBA 02/2010

Therapy/Procedure

1	Immunotherapy 01/2020
1	Intranasal Administration 05/2016
1	Microspheres (Microsphere) 05/2016
1	Drug Therapy (Chemotherapy) 02/2010